Bronchopulmonary Dysplasia Treatment for Preterm Infants Utilizes Mesenchymal Stem Cells [MSC].

Mesenchymal Stem Cell transplants may prevent preterm babies from developing BPD.

Researchers at the Samsung Medical Center and Biomedical Research Institute in Seoul, South Korea, have succeeded in treating and preventing Bronchopulmonary Dysplasia [BPD], a chronic lung disease affecting preterm infants.  In a Phase 1 clinical trial, the research team was successful in transplanting mesenchymal stem cells to repair damage and underdevelopment within the infant’s lungs.

Of the 500,000 babies born premature every year, those that suffer from BPD require years of oxygen therapy and run the risk of never having normal lung function.  Due to the unique capabilities of mesenchymal stem cells [the type of stem cells found in dental stem cells], preterm infants may soon have a strong chance of avoiding BPD and growing up with normal lung development.

To learn more about the value of preserving your own MSCs for use in future regenerative therapies and how to bank your own stem cells through a non-invasive and affordable method by recovering your dental pulp stem cells, visit StemSave or call 877-783-6728 (877-StemSave) today.

 

To view the full article, click here.

 

The Future of Regenerative Medicine is Now™.